Table 1.
Original APA guidelines | Stricter guidelines used in this review |
---|---|
I: At least two good between- group design experiments demonstrating efficacy in one or more of the following ways: | I: Efficacy |
A. Superior (based on statistical significance alone) to pill or psychological placebo or to another treatment |
A. For rating efficacy rely on a. Systematic review and meta-analysis (recent: last 2 years) b. Multi-centre Randomized Controlled Trials (RCTs) |
B. Equivalent to an already established treatment in experiments with adequate statistical power, considered to be approximately 30 per group | B. Consider clinical significance (Remission) in addition to statistical significance (Cohen’s D) |
C. Consider long-term efficacy in addition to short-term efficacy | |
D. Statistical superiority to semi-active control groups or inert placebo | |
E. Equivalence to already established treatment (active treatments) | |
F. Consider bias via meta-analysis, e.g. publication bias | |
OR | AND |
II: A large series of single-case design experiments (N > 9) demonstrating efficacy. These experiments must have: | II: Effectiveness |
A. Used good experimental designs and | A. Address generalization of research findings to non-research settings and diverse populations: Open-label studies |
B. Compared the intervention to another treatment as in I A | B. Cohen’s D and Remission rates |
C. Safety and Side-effect profile | |
D. Cost–benefit analysis | |
Further criteria for both I and II | |
III: Experiments must be conducted with treatment manuals | III: Experiments must be conducted with treatment manuals. In relation to neurofeedback studies, this is operationalized to restrict selection to those studies employing standard protocols: TBR, SMR and SCP protocols (see text for detail) |
IV: Characteristics of the client samples must be clearly specified | IV: Characteristics of the client samples must be clearly specified |
V: Effects must have been demonstrated by at least two different investigators or investigating teams | V: Independent replication |